medigraphic.com
ISSN 1405-8871 (Print)

2023, Number 3

<< Back Next >>

Aten Fam 2023; 30 (3)

Cardiovascular Risk Estimation with Globorisk in a Family Medicine Unit

García-Jiménez Y, Soto-Ávila DA, Palacios-Tapia A, García-Morales G

Language: Spanish
References: 27
Page: 212-218
PDF size: 165.32 Kb.


ABSTRACT

Objective: To estimate cardiovascular risk using Globorisk in patients of a family medicine unit. Methods: crosssectional analytical study carried out from August to December 2021, using a non-probabilistic sampling. This sample consisted of 750 people aged 40 to 60 years. Globorisk was used to estimate cardiovascular risk. The International Physical Activity Questionnaire (IPAQ) was also used; blood pressure, weight, height, and body mass index were measured. Triglyceride, cholesterol, and glucose levels were collected. The magnitude of the association effect was estimated with Odds Ratio and statistical significance by Mantel-Haenszel χ2 , with a confidence interval of 95%. Results: The high to very high cardiovascular risk was 27.8% (209/750). 76.3% of participants were overweightobese (572/750). The factors associated with high to very high cardiovascular risk were: male gender (OR 15.8; 95% CI 7.8-32.1), low schooling level (OR 2.9; 95% CI 1.6-5.3), an unpaid occupation (OR 3.2; 95% CI 2.0-5.3), living at home without a partner (OR 2.6; 95% CI 1.6-4.3), diabetes (OR 10.8; 95% CI 5.2-22.4), cholesterol level higher than 200 mg/dL (OR 2.7; 95% CI 1.7-4.5), and do light physical activity (OR 2.3; 95% CI 1.4-3.9). Conclusion: three out of ten analyzed persons presented high to very high cardiovascular risk; the associated factors were related to gender, education, occupation, and other metabolic variables.


REFERENCES

  1. Thomas H, Diamond J, Vieco A, Chaudhuri S,Shinnar E, Cromer S, et al. Global Atlas of CardiovascularDisease 2000-2016: The Path to Preventionand Control. Glob Heart. 2018;13(3):143-163.

  2. Jagannathan R, Patel SA, Ali MK, Narayan KMV.Global Updates on Cardiovascular Disease MortalityTrends and Attribution of Traditional RiskFactors. Curr Diab Rep. 2019;19(7):44.

  3. GBD 2016 Stroke Collaborators. Global, regional,and national burden of stroke, 1990-2016: a systematicanalysis for the Global Burden of DiseaseStudy 2016. Lancet Neurol. 2019;18(5):439-458.

  4. Secretaria de Salud. Panorama epidemiológico delas enfermedades no transmisibles en México [Internet].[Citado 2022 junio 28]. Disponible en:https://www.gob.mx/cms/uploads/attachment/file/745354/PanoEpi_ENT_Cierre2021.pdf

  5. Mostaza JM, Pintó X, Armario P, Masana L, AscasoFJ, Valdivielso P et al. Standards for globalcardiovascular risk management arteriosclerosis.Estándares SEA 2019 para el control global delriesgo cardiovascular. Clin Investig Arterioscler.2019;31(Suppl)1:1-43.

  6. Timmis A, Townsend N, Gale CP, Torbica A,Lettino M, Petersen SE, et al. European Societyof Cardiology: Cardiovascular Disease Statistics2019. Eur Heart J. 2020;41(1):12-85.

  7. Sacramento-Pacheco J, Duarte-Clíments G, Gómez-Salgado J, Romero-Martín M, Sánchez-GómezMB. Cardiovascular risk assessment tools: A scopingreview. Aust Crit Care. 2019;32(6):540-559.

  8. Maharani A, Sujarwoto S, Praveen D, Oceandy D,Tampubolon G, Patel A. Cardiovascular diseaserisk factor prevalence and estimated 10-year cardiovascularrisk scores in Indonesia: The SMARThealth Extend study. PLoS One. 2019.

  9. Selvarajah S, Kaur G, Haniff J, Cheong KC, HiongTG, Van Der Graaf Y, et al. Comparison of theFramingham Risk Score, SCORE and WHO/ISHcardiovascular risk prediction models in an Asianpopulation. Int J Cardiol. 2014;176(1):211-218.

  10. Hajifathalian K, Ueda P, Lu Y, Woodwart M, AhmadvandA, Aguilar-Salinas CA, et al. A novel riskscore to predict cardiovascular disease risk in nationalpopulations (Globorisk): a pooled analysisof prospective cohorts and health examination surveys.Lancet Diabetes Endocrinol. 2015;3(5):339-355.

  11. Núñez-Rocha GM, López-Enriquez I, Ramos-Hernández SR, Ramos-Peña EG, Guevara-ValtierMC, González-Treviño IM. Riesgo cardiovascularen pacientes de primer nivel de atención. Rev SaludPublica Nutr. 2015;14(1):1-8.

  12. Marques Da Silva P, Lima MJ, Neves PM, Espigade Macedo M. Prevalence of cardiovascular riskfactors and other comorbidities in patients withhypertension in Portuguese primary health carepopulations: The PRECISE study. Rev Port Cardiol.2019;38(6):427-437.

  13. Che Nawi CMNH, Omar MA, Keegan T, YuYP, Musa KI. The Ten-Year Risk Prediction forCardiovascular Disease for Malaysian Adults Usingthe Laboratory-Based and Office-Based (Globorisk)Prediction Model. Medicina (Kaunas).2022;58(5):656.

  14. Ueda P, Woodward M, Lu Y, Hajifathalian K, Al-Wotayan R, Aguilar-Salinas CA, et al. Laboratorybasedand office-based risk scores and charts topredict 10-year risk of cardiovascular disease in182 countries: a pooled analysis of prospective cohortsand health surveys. Lancet Diabetes Endocrinol.2017;5(3):196-213.

  15. Tratamiento de dislipidemias en el adulto. Guíade Práctica Clínica: Evidencias y Recomendaciones[Internet]. [Citado 2022 julio 09] Disponibleen: http://www.cenetec-difusion.com/CMGPC/GPC-IMSS-233-22/ER.pdf

  16. Vignolo J, Vacarezza M, Álvarez C, Sosa A. Nivelesde atención, de prevención y atención primaria dela salud. Arch Med Int. 2011; 33(1):7-11.

  17. Castillo-Sánchez M, Galera-Morcillo L, Sánchez-Sánchez JA, Menárguez-Puche JF. Sobrediagnósticoy sobretratamiento en el ámbito cardiovascular:factores de riesgo, no enfermedades. Aten Primaria.2018;50(Suppl 2):20-29.

  18. Reynolds R, Dennis S, Hasan I, Slewa J, ChenW, Tian D, et al. A systematic review of chronicdisease management interventions in primary care.BMC Fam Pract. 2018;19(1):11.

  19. Mendoza-Herrera K, Pedroza-Tobías A, Hernández-Alcaraz C, Ávila-Burgos L, Aguilar-SalinasCA, Barquera S. Attributable Burden and Expenditureof Cardiovascular Diseases and AssociatedRisk Factors in Mexico and other Selected Mega-Countries. Int J Environ Res Public Health. 2019;16(20):4041.

  20. Carrera Y. Cuestionario Internacional de ActividadFísica (IPAQ). Rev Enferm del Trab.2017;7(11):49-54.

  21. Organización Panamericana de la Salud. Especificacionestécnicas de la OMS para dispositivosautomáticos de medición de la presión arterial noinvasivos y con brazalete. [Internet]. [Citado 2022Junio 29]. Disponible en: https://iris.paho.org/handle/10665.2/53145

  22. Wagner RG, Crowther NJ, Micklesfield LK, BouaPR, Nonterah EA, Mashinya F, et al. Estimatingthe burden of cardiovascular risk in communitydwellers over 40 years old in South Africa, Kenya,Burkina Faso and Ghana. BMJ Glob Health.2021;6(1):e003499.

  23. Querales Carrasquel M, Rojas Pacheco S, Silva E,Ochoa J, Santiago K, Adames J, et al. Factores deriesgo cardiovascular en comunidades urbana y rural:Tinaquillo, Venezuela. Rev. Salud Pública. 19(2):188-193, 2017.

  24. Lorente Ros A, Rajjoub Al-Mahdi EA, MartínezMoya R, Zamorano Gómez JL. Factores de riesgocardiovascular. Medicine. 2021;13(36):2071-80.

  25. Ramírez-Iñiguez de la Torre MV, Vicente-HerreroMT, López-González AA, Capdevila-García L.Factores de riesgo cardiovascular y su relación confactores sociodemográficos y laborales en trabajadoresaparentemente sanos. Rev Asoc Esp EspecMed Trab. 2017; 26(4):257-265.

  26. Borhanuddin B, Mohd Nawi A, Shah SA, AbdullahN, Syed Zakaria SZ, Kamaruddin MA, et al. 10-Year Cardiovascular Disease Risk Estimation Basedon Lipid Profile-Based and BMI-Based FraminghamRisk Scores across Multiple SociodemographicCharacteristics: The Malaysian Cohort Project.Scientific World Journal. 2018;17:2979206.

  27. Pinho-Gomes AC, Peters SAE, Thomson B,Woodward M. Sex differences in prevalence, treatmentand control of cardiovascular risk factors inEngland. Heart 2021; 107:462–467.García-Jiménez Y y cols.Aten Fam. 2023;24(3):212-218. http://dx.doi.org/10.22201/fm.14058871p.2023.3.85782




2020     |     www.medigraphic.com